Changing Of The Guard At Merck KGaA With Garijo Succeeding Oschmann As CEO
Ensures Smooth Leadership Transition
Executive Summary
The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant step on the road to addressing gender inequality at the very top level of management in the world of big pharma.
You may also be interested in...
The Old Order Changeth: Women CEOs at Foreign Firms In India Chart New Course
Foreign firms including Merck KGaA, Boehringer Ingelheim, Takeda and Sanofi’s vaccines business are being led by women in India, a fiercely competitive, largely out-of-pocket market. There’s a lot riding on these female leaders as they seek to drive business growth and potentially change the paradigm around the gender gap in pharma at the top.
J.P. Morgan Day 1: Companies Make Deal-Making, COVID-19 Promises
Daily round-up from the virtual J.P. Morgan Healthcare Conference: Business development is key topic for Amgen and Vertex; BioNTech talks COVID-19 vaccine supply while Merck KGAA's new CEO pledges to rise to meet the challenges posed by COVID-19.
J.P. Morgan Day 1: Companies Make Deal-Making, COVID-19 Promises
Daily round-up from the virtual J.P. Morgan Healthcare Conference: Business development is key topic for Amgen and Vertex; BioNTech talks COVID-19 vaccine supply while Merck KGAA's new CEO pledges to rise to meet the challenges posed by COVID-19.